Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT00075504What this trial is testingTriapine and Gemcitabine Hydrochloride in Gallbladder CancerWho this might be right forStage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT02042443What this trial is testingTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryWho this might be right forAdult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more National Cancer Institute (NCI) 53
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT04072445What this trial is testingTrifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Study completedNCT03768414What this trial is testingGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersWho this might be right forStage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8+14 more SWOG Cancer Research Network 452
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Ended earlyNCT00387348What this trial is testingEscitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerWho this might be right forColorectal CancerDepressionEsophageal Cancer+7 more Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Study completedNCT02392637What this trial is testingGemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersWho this might be right forStage III Intrahepatic Cholangiocarcinoma AJCC v7Stage IIIA Gallbladder Cancer AJCC v7Stage IIIB Gallbladder Cancer AJCC v7+6 more M.D. Anderson Cancer Center 62
Early research (Phase 1)Study completedNCT01825603What this trial is testingADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerWho this might be right forAmpulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more University of Nebraska 17
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Active Not RecruitingNCT03257761What this trial is testingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more University of Southern California 55
Testing effectiveness (Phase 2)Study completedNCT03278106What this trial is testingTAS-102 in Treating Advanced Biliary Tract CancersWho this might be right forCholangiocarcinomaStage III Gallbladder Cancer AJCC v7Stage IIIA Gallbladder Cancer AJCC v7+4 more Mayo Clinic 28
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT01859182What this trial is testingSelumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more National Cancer Institute (NCI)